The pipeline
8 programmes in development for hair loss and hair regeneration. Sorted by phase, latest first.
8 programmes
| Programme | Developer | Phase | Approach | Mechanism | Last activity |
|---|---|---|---|---|---|
| CKD-843 Medium· 3 trials | Chong Kun Dang Pharmaceutical | Phase 3 | Injectable | 5α-reductase inhibitor | 16 months ago |
| Amlitelimab High· 1 trials | Sanofi | Phase 2 | BiologicInjectable | Immunomodulator | 1 month ago |
| BNZ-1 Medium· 1 trials | Equillium | Phase 2 | BiologicInjectable | Immunomodulator | No public activity in over 18 months |
| Daxdilimab High· 1 trials | Amgen | Phase 2 | BiologicInjectable | Immunomodulator | No public activity in over 18 months |
| HMI-115 Medium· 2 trials | Hope Medicine | Phase 2 | InjectableBiologic | Prolactin receptor | 14 months ago |
| Rosnilimab High· 1 trials | AnaptysBio | Phase 2 | BiologicInjectable | Immunomodulator | No public activity in over 18 months |
| Epibiotech dermal papilla cell therapy Medium· 1 trials | Epibiotech | Phase 1/2 | Cell therapyInjectable | Stem cell activation | 2 months ago |
| AMP-303 Medium | Amplifica | Phase 1 | Injectable | Signalling peptide | Never |